ヒト用経口ワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Human Oral Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16419 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ヒト用経口ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のヒト用経口ワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のヒト用経口ワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ヒト用経口ワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他 用途別セグメントは次のように区分されます。 ・公共、民間 世界のヒト用経口ワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ヒト用経口ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒト用経口ワクチンメーカーの企業概要、2019年～2021年までのヒト用経口ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒト用経口ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ヒト用経口ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのヒト用経口ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのヒト用経口ワクチン市場予測を収録しています。 ・第12、13、14章では、ヒト用経口ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Merck、GSK、Sanofi、Lanzhou Institute、Serum Institute、Valneva、Shanghai United Cell、Bibcol、PaxVax、Vabiotech、Tiantan Biological、EuBiologics、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ロタウイルスワクチン、コレラワクチン、経口ポリオワクチン、その他 ・用途別分析2016年-2026年：公共、民間 ・ヒト用経口ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト用経口ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト用経口ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト用経口ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト用経口ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Human Oral Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Human Oral Vaccine size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Human Oral Vaccine market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Human Oral Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Market segment by Application can be divided into
Public
Private

The key market players for global Human Oral Vaccine market are listed below:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Human Oral Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Oral Vaccine, with price, sales, revenue and global market share of Human Oral Vaccine from 2019 to 2021.
Chapter 3, the Human Oral Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Oral Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Human Oral Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Human Oral Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Human Oral Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Oral Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Oral Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Public
1.3.3 Private
1.4 Global Human Oral Vaccine Market Size & Forecast
1.4.1 Global Human Oral Vaccine Sales in Value (2016-2026))
1.4.2 Global Human Oral Vaccine Sales in Volume (2016-2026)
1.4.3 Global Human Oral Vaccine Price by Type (2016-2026) & (US$/Unit)
1.5 Global Human Oral Vaccine Production Capacity Analysis
1.5.1 Global Human Oral Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Human Oral Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Oral Vaccine Market Drivers
1.6.2 Human Oral Vaccine Market Restraints
1.6.3 Human Oral Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Human Oral Vaccine Product and Services
2.1.4 Merck Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Human Oral Vaccine Product and Services
2.2.4 GSK Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Human Oral Vaccine Product and Services
2.3.4 Sanofi Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Lanzhou Institute
2.4.1 Lanzhou Institute Details
2.4.2 Lanzhou Institute Major Business
2.4.3 Lanzhou Institute Human Oral Vaccine Product and Services
2.4.4 Lanzhou Institute Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Serum Institute
2.5.1 Serum Institute Details
2.5.2 Serum Institute Major Business
2.5.3 Serum Institute Human Oral Vaccine Product and Services
2.5.4 Serum Institute Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Valneva
2.6.1 Valneva Details
2.6.2 Valneva Major Business
2.6.3 Valneva Human Oral Vaccine Product and Services
2.6.4 Valneva Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shanghai United Cell
2.7.1 Shanghai United Cell Details
2.7.2 Shanghai United Cell Major Business
2.7.3 Shanghai United Cell Human Oral Vaccine Product and Services
2.7.4 Shanghai United Cell Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Bibcol
2.8.1 Bibcol Details
2.8.2 Bibcol Major Business
2.8.3 Bibcol Human Oral Vaccine Product and Services
2.8.4 Bibcol Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 PaxVax
2.9.1 PaxVax Details
2.9.2 PaxVax Major Business
2.9.3 PaxVax Human Oral Vaccine Product and Services
2.9.4 PaxVax Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Vabiotech
2.10.1 Vabiotech Details
2.10.2 Vabiotech Major Business
2.10.3 Vabiotech Human Oral Vaccine Product and Services
2.10.4 Vabiotech Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Tiantan Biological
2.11.1 Tiantan Biological Details
2.11.2 Tiantan Biological Major Business
2.11.3 Tiantan Biological Human Oral Vaccine Product and Services
2.11.4 Tiantan Biological Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 EuBiologics
2.12.1 EuBiologics Details
2.12.2 EuBiologics Major Business
2.12.3 EuBiologics Human Oral Vaccine Product and Services
2.12.4 EuBiologics Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Panacea Biotec Ltd
2.13.1 Panacea Biotec Ltd Details
2.13.2 Panacea Biotec Ltd Major Business
2.13.3 Panacea Biotec Ltd Human Oral Vaccine Product and Services
2.13.4 Panacea Biotec Ltd Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Bio-Med
2.14.1 Bio-Med Details
2.14.2 Bio-Med Major Business
2.14.3 Bio-Med Human Oral Vaccine Product and Services
2.14.4 Bio-Med Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Halfkin Bio-Pharmaceuticals
2.15.1 Halfkin Bio-Pharmaceuticals Details
2.15.2 Halfkin Bio-Pharmaceuticals Major Business
2.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
2.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Human Oral Vaccine Sales by Manufacturer
3.1 Global Human Oral Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Oral Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Oral Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Oral Vaccine Manufacturer Market Share
3.4.2 Top 6 Human Oral Vaccine Manufacturer Market Share
3.5 Global Human Oral Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Oral Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Oral Vaccine Market Size by Region
4.1.1 Global Human Oral Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Human Oral Vaccine Revenue by Region (2016-2026)
4.2 North America Human Oral Vaccine Revenue (2016-2026)
4.3 Europe Human Oral Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Human Oral Vaccine Revenue (2016-2026)
4.5 South America Human Oral Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Human Oral Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Oral Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Human Oral Vaccine Revenue by Type (2016-2026)
5.3 Global Human Oral Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Oral Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Human Oral Vaccine Revenue by Application (2016-2026)
6.3 Global Human Oral Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Oral Vaccine Sales by Type (2016-2026)
7.2 North America Human Oral Vaccine Sales by Application (2016-2026)
7.3 North America Human Oral Vaccine Market Size by Country
7.3.1 North America Human Oral Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Human Oral Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Oral Vaccine Sales by Type (2016-2026)
8.2 Europe Human Oral Vaccine Sales by Application (2016-2026)
8.3 Europe Human Oral Vaccine Market Size by Country
8.3.1 Europe Human Oral Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Oral Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Oral Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Human Oral Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Human Oral Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Oral Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Oral Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Oral Vaccine Sales by Type (2016-2026)
10.2 South America Human Oral Vaccine Sales by Application (2016-2026)
10.3 South America Human Oral Vaccine Market Size by Country
10.3.1 South America Human Oral Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Human Oral Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Oral Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Human Oral Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Human Oral Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Oral Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Oral Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Oral Vaccine Typical Distributors
12.3 Human Oral Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Human Oral Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Oral Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Human Oral Vaccine Product and Services
Table 6. Merck Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Human Oral Vaccine Product and Services
Table 10. GSK Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Human Oral Vaccine Product and Services
Table 14. Sanofi Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Lanzhou Institute Basic Information, Manufacturing Base and Competitors
Table 16. Lanzhou Institute Major Business
Table 17. Lanzhou Institute Human Oral Vaccine Product and Services
Table 18. Lanzhou Institute Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute Major Business
Table 21. Serum Institute Human Oral Vaccine Product and Services
Table 22. Serum Institute Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Valneva Basic Information, Manufacturing Base and Competitors
Table 24. Valneva Major Business
Table 25. Valneva Human Oral Vaccine Product and Services
Table 26. Valneva Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Shanghai United Cell Basic Information, Manufacturing Base and Competitors
Table 28. Shanghai United Cell Major Business
Table 29. Shanghai United Cell Human Oral Vaccine Product and Services
Table 30. Shanghai United Cell Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bibcol Basic Information, Manufacturing Base and Competitors
Table 32. Bibcol Major Business
Table 33. Bibcol Human Oral Vaccine Product and Services
Table 34. Bibcol Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PaxVax Basic Information, Manufacturing Base and Competitors
Table 36. PaxVax Major Business
Table 37. PaxVax Human Oral Vaccine Product and Services
Table 38. PaxVax Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vabiotech Basic Information, Manufacturing Base and Competitors
Table 40. Vabiotech Major Business
Table 41. Vabiotech Human Oral Vaccine Product and Services
Table 42. Vabiotech Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 44. Tiantan Biological Major Business
Table 45. Tiantan Biological Human Oral Vaccine Product and Services
Table 46. Tiantan Biological Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 48. EuBiologics Major Business
Table 49. EuBiologics Human Oral Vaccine Product and Services
Table 50. EuBiologics Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Panacea Biotec Ltd Major Business
Table 53. Panacea Biotec Ltd Human Oral Vaccine Product and Services
Table 54. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 56. Bio-Med Major Business
Table 57. Bio-Med Human Oral Vaccine Product and Services
Table 58. Bio-Med Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 60. Halfkin Bio-Pharmaceuticals Major Business
Table 61. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product and Services
Table 62. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Human Oral Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Human Oral Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Human Oral Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Human Oral Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Human Oral Vaccine Production Site of Key Manufacturer
Table 68. Human Oral Vaccine New Entrant and Capacity Expansion Plans
Table 69. Human Oral Vaccine Mergers & Acquisitions in the Past Five Years
Table 70. Global Human Oral Vaccine Sales by Region (2016-2021e) & (K Units)
Table 71. Global Human Oral Vaccine Sales by Region (2021-2026) & (K Units)
Table 72. Global Human Oral Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 73. Global Human Oral Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 74. Global Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 75. Global Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 76. Global Human Oral Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 77. Global Human Oral Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 78. Global Human Oral Vaccine Price by Type (2016-2021e) & (US$/Unit)
Table 79. Global Human Oral Vaccine Price by Type (2021-2026) & (US$/Unit)
Table 80. Global Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 81. Global Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 82. Global Human Oral Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 83. Global Human Oral Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 84. Global Human Oral Vaccine Price by Application (2016-2021e) & (US$/Unit)
Table 85. Global Human Oral Vaccine Price by Application (2021-2026) & (US$/Unit)
Table 86. North America Human Oral Vaccine Sales by Country (2016-2021e) & (K Units)
Table 87. North America Human Oral Vaccine Sales by Country (2021-2026) & (K Units)
Table 88. North America Human Oral Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 89. North America Human Oral Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 90. North America Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 91. North America Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 92. North America Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 93. North America Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 94. Europe Human Oral Vaccine Sales by Country (2016-2021e) & (K Units)
Table 95. Europe Human Oral Vaccine Sales by Country (2021-2026) & (K Units)
Table 96. Europe Human Oral Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 97. Europe Human Oral Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 98. Europe Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 99. Europe Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 100. Europe Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 101. Europe Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 102. Asia-Pacific Human Oral Vaccine Sales by Region (2016-2021e) & (K Units)
Table 103. Asia-Pacific Human Oral Vaccine Sales by Region (2021-2026) & (K Units)
Table 104. Asia-Pacific Human Oral Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 105. Asia-Pacific Human Oral Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 106. Asia-Pacific Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 107. Asia-Pacific Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 108. Asia-Pacific Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 109. Asia-Pacific Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 110. South America Human Oral Vaccine Sales by Country (2016-2021e) & (K Units)
Table 111. South America Human Oral Vaccine Sales by Country (2021-2026) & (K Units)
Table 112. South America Human Oral Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 113. South America Human Oral Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 114. South America Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 115. South America Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 116. South America Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 117. South America Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 118. Middle East & Africa Human Oral Vaccine Sales by Country (2016-2021e) & (K Units)
Table 119. Middle East & Africa Human Oral Vaccine Sales by Country (2021-2026) & (K Units)
Table 120. Middle East & Africa Human Oral Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 121. Middle East & Africa Human Oral Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 122. Middle East & Africa Human Oral Vaccine Sales by Type (2016-2021e) & (K Units)
Table 123. Middle East & Africa Human Oral Vaccine Sales by Type (2021-2026) & (K Units)
Table 124. Middle East & Africa Human Oral Vaccine Sales by Application (2016-2021e) & (K Units)
Table 125. Middle East & Africa Human Oral Vaccine Sales by Application (2021-2026) & (K Units)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Human Oral Vaccine Typical Distributors
Table 129. Human Oral Vaccine Typical Customers
List of Figures
Figure 1. Human Oral Vaccine Picture
Figure 2. Global Human Oral Vaccine Sales Market Share by Type in 2020
Figure 3. Rotavirus Vaccine
Figure 4. Cholera Vaccine
Figure 5. Oral Polio Vaccine
Figure 6. Other
Figure 7. Global Human Oral Vaccine Sales Market Share by Application in 2020
Figure 8. Public
Figure 9. Private
Figure 10. Global Human Oral Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Human Oral Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Human Oral Vaccine Sales (2016-2026) & (K Units)
Figure 13. Global Human Oral Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Human Oral Vaccine Production Capacity (2016-2026) & (K Units)
Figure 15. Global Human Oral Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Human Oral Vaccine Market Drivers
Figure 17. Human Oral Vaccine Market Restraints
Figure 18. Human Oral Vaccine Market Trends
Figure 19. Global Human Oral Vaccine Sales Market Share by Manufacturer in 2020
Figure 20. Global Human Oral Vaccine Revenue Market Share by Manufacturer in 2020
Figure 21. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Human Oral Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Human Oral Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Human Oral Vaccine Sales Market Share by Region (2016-2026)
Figure 25. Global Human Oral Vaccine Revenue Market Share by Region (2016-2026)
Figure 26. North America Human Oral Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Europe Human Oral Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Human Oral Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. South America Human Oral Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Human Oral Vaccine Revenue (2016-2026) & (USD Million)
Figure 31. Global Human Oral Vaccine Sales Market Share by Type (2016-2026)
Figure 32. Global Human Oral Vaccine Revenue Market Share by Type (2016-2026)
Figure 33. Global Human Oral Vaccine Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 35. Global Human Oral Vaccine Revenue Market Share by Application (2016-2026)
Figure 36. Global Human Oral Vaccine Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Human Oral Vaccine Sales Market Share by Type (2016-2026)
Figure 38. North America Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 39. North America Human Oral Vaccine Sales Market Share by Country (2016-2026)
Figure 40. North America Human Oral Vaccine Revenue Market Share by Country (2016-2026)
Figure 41. United States Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Human Oral Vaccine Sales Market Share by Type (2016-2026)
Figure 45. Europe Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 46. Europe Human Oral Vaccine Sales Market Share by Country (2016-2026)
Figure 47. Europe Human Oral Vaccine Revenue Market Share by Country (2016-2026)
Figure 48. Germany Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Human Oral Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Human Oral Vaccine Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Human Oral Vaccine Revenue Market Share by Region (2016-2026)
Figure 57. China Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Human Oral Vaccine Sales Market Share by Type (2016-2026)
Figure 64. South America Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Human Oral Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Human Oral Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Human Oral Vaccine Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Human Oral Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Human Oral Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---